Skip to main navigation Skip to search Skip to main content

Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII (atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model

  • Cynthia Soon
  • , Paul Donnelly
  • , Bradley Turner
  • , Lin Hung
  • , Peter Crouch
  • , Nicki Sherratt
  • , Jiang-Li Tan
  • , Nastasia Lim
  • , Linh Lam
  • , Laura Bica
  • , Sin Chun Lim
  • , James Hickey
  • , Julia Morizzi
  • , Andrew Powell
  • , David Finkelstein
  • , Janetta Culvenor
  • , Colin Masters
  • , James Duce
  • , Anthony White
  • , Kevin Barnham
  • Qiao-Xin Lin

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: CuII(atsm) [(diacetylbis(N(4)-methylthiosemicarbazonato) copper(II)] was orally administrated to transgenic SOD1G93A mice. Results: Treatment significantly prolonged lifespan with preservation of motor neurons. Reduced protein oxidation, attenuated astrocyte, and microglial activation also resulted from treatment. Conclusion: CuII(atsm) is neuroprotective in this model even when treatment begins after the onset of disease symptoms. Significance: The drug has therapeutic potential for amyotrophic lateral sclerosis.
Original languageEnglish
Pages (from-to)44035 - 44044
Number of pages10
JournalJournal of Biological Chemistry
Volume286
Issue number51
DOIs
Publication statusPublished - 2011

Cite this